FDA approves Protagonist and Takeda’s drug for rare blood cancer Mimrylo, a weekly injection, is a new kind of treatment for polycythemia vera By Adam FeuersteinAug. 30, 2026 Senior Writer, Biotech

https://www.statnews.com/2026/08/30/fda-approves-mimrylo-takeda-protagonist-treatment-for-polycythemia-vera/